Technologies Available for Licensing
ANTHRAX VACCINE
Using the nontoxic PA protein from B. anthracis, a method and composition for use in inducing an immune response which is protective against anthrax in subjects is described.
Docket:RIID 98-21
Publication/Issued No.:6,770,479
Publication/Issue Date:2004-08-03
Categories: Vaccine
More Detail:Visit USPTO.GOV
Lab:RIID
Inventor(s):LEE, J.; PUSHKO, P.; PARKER, M.; SMITH, J.; WELKOS, S.
Abstract:Download